Premium
Increased cytotoxic potential of microglia from ALS‐transgenic mice
Author(s) -
Weydt Patrick,
Yuen Eric C.,
Ransom Bruce R.,
Möller Thomas
Publication year - 2004
Publication title -
glia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.954
H-Index - 164
eISSN - 1098-1136
pISSN - 0894-1491
DOI - 10.1002/glia.20062
Subject(s) - microglia , sod1 , amyotrophic lateral sclerosis , biology , genetically modified mouse , transgene , motor neuron , superoxide dismutase , neuroscience , cytotoxic t cell , neuron , immunology , pathology , endocrinology , inflammation , gene , disease , oxidative stress , medicine , biochemistry , in vitro , spinal cord
Amyotrophic lateral sclerosis is a fatal, adult‐onset motor neuron disease. A subset of cases is caused by mutations of superoxide dismutase 1 (SOD1) gene. The mechanisms how the mutations in this ubiquitous enzyme mediate the highly selective motor neuron degeneration, however, remain poorly understood. Recent results from transgenic animal models suggest a “non‐cell autonomous” mechanism; i.e., cells other than neurons play an active role in motor neuron death. To investigate a possible effect of mtSOD1 on microglial cells, we compared primary cultured microglia from mtSOD1‐transgenic mice and nontransgenic litter controls at neonatal (3 days) and adult (60 days) age. We found that mtSOD1 expression increases the production of TNF‐α and attenuates IL‐6‐release by LPS‐activated adult microglia. Neonatal microglia, however, showed no differences. Our findings suggest an increased cytotoxic potential of adult mtSOD1 microglia, which only becomes apparent after microglial activation. © 2004 Wiley‐Liss, Inc.